Efficacy and Safety of Baricitinib in the Post-intracerebral Hemorrhage Pulmonary Injury
Clinical trial NCT06548802 · RECRUITING
Trial details
- NCT number
- NCT06548802
- Sponsor
- Tianjin Medical University General Hospital
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-29
- Primary completion
- 2026-06-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.